Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Maybe partnerships are coming soon

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Mar 05, 2021 11:31am

101 Views

Post# 32728234

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Maybe partnerships are coming soon

Yeah -- where's those institutions averaging in? I realize most of this is the NASDAQ volatility and adjusting to higher long rates. It should be over fairly soon, but this may have done the trick to shake out the day traders and put it in to patient hands. Maybe AACR will get it back up there!